Blast–related disinhibition and risk seeking in mice and combat Veterans: Potential role for dysfunctional phasic dopamine release von Schindler, A.G, Meabon, J.S, Pagulayan, K.F, Hendrickson, R.C, Meeker, K.D, Cline, M, Li, G, Sikkema, C, Wilkinson, C.W, Perl, D.P, Raskind, M.R, Peskind, E.R, Clark, J.J, Cook, D.G

Volltext

Blast exposure causes dynamic microglial/macrophage responses and microdomains of brain microvessel dysfunction von Huber, B.R, Meabon, J.S, Hoffer, Z.S, Zhang, J, Hoekstra, J.G, Pagulayan, K.F, McMillan, P.J, Mayer, C.L, Banks, W.A, Kraemer, B.C, Raskind, M.A, McGavern, D.B, Peskind, E.R, Cook, D.G

Volltext

Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men von Cherrier, M.M, Matsumoto, A.M, Amory, J.K, Johnson, M, Craft, S, Peskind, E.R, Raskind, M.A

Volltext

Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: Evidence of compensatory changes von Szot, P, White, S.S, Greenup, J.L, Leverenz, J.B, Peskind, E.R, Raskind, M.A

Volltext

Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease von Bekris, L.M, Galloway, N.M, Millard, S, Lockhart, D, Li, G, Galasko, D.R, Farlow, M.R, Clark, C.M, Quinn, J.F, Kaye, J.A, Schellenberg, G.D, Leverenz, J.B, Seubert, P, Tsuang, D.W, Peskind, E.R, Yu, C.E

Volltext

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension von RASKIND, M. A, PESKIND, E. R, WESSEL, T, YUAN, W

Volltext

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease von Britschgi, M, Olin, C.E, Johns, H.T, Takeda-Uchimura, Y, LeMieux, M.C, Rufibach, K, Rajadas, J, Zhang, H, Tomooka, B, Robinson, W.H, Clark, C.M, Fagan, A.M, Galasko, D.R, Holtzman, D.M, Jutel, M, Kaye, J.A, Lemere, C.A, Leszek, J, Li, G, Peskind, E.R, Quinn, J.F, Yesavage, J.A, Ghiso, J.A, Wyss-Coray, T

Volltext

Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease von Bekris, Lynn M., Tsuang, Debby W., Peskind, Elaine R., Yu, Chang E., Montine, Thomas J., Zhang, Jing, Zabetian, Cyrus P., Leverenz, James B.

Volltext

Steroid-induced elevation of glucose in Alzheimer’s disease: relationship to gender, apolipoprotein E genotype and cognition von Aisen, P.S, Berg, J.D, Craft, S, Peskind, E.R, Sano, M, Teri, L, Mulnard, R.A, Thomas, R.G, Thal, L.J

Volltext

Adjudicating Mild Cognitive Impairment Due to Alzheimer’s Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial von Schneider, Lon S., Bennett, D. A., Farlow, M. R., Peskind, E. R., Raskind, M. A., Sano, M., Stern, Y., Haneline, S., Welsh-Bohmer, K. A., O’Neil, J., Walter, R., Maresca, S., Culp, M., Alexander, R., Saunders, A. M., Burns, D. K., Chiang, C.

Volltext

ADAM10 expression and promoter haplotype in Alzheimer's disease von Bekris, Lynn M, Lutz, Franziska, Li, Gail, Galasko, Douglas R, Farlow, Martin R, Quinn, Joseph F, Kaye, Jeffrey A, Leverenz, James B, Tsuang, Debby W, Montine, Thomas J, Peskind, Elaine R, Yu, Chang-En

Volltext

ABCB1 Genotype and CSF β-Amyloid in Alzheimer Disease von Kohen, R., Shofer, J.B., Korvatska, O., Petrie, E.C., Wang, L.Y., Schellenberg, G.D., Peskind, E.R., Wilkinson, C.W.

Volltext

APP Processing Genes and Cerebrospinal Fluid APP Cleavage Product Levels in Alzheimer’s Disease von Bekris, L.M., Galloway, N.M., Millard, S., Lockhart, D., Li, G., Galasko, D.R., Farlow, M.R., Clark, C.M., Quinn, J.F., Kaye, J.A., Schellenberg, G.D., Leverenz, J.B., Seubert, P., Tsuang, D.W., Peskind, E.R., Yu, C.E.

Volltext

CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease von SAMUELS, S. C, SILVERMAN, J. M, MARIN, D. B, PESKIND, E. R, YOUNKI, S. G, GREENBERG, D. A, SCHNUR, E, SANTORO, J, DAVIS, K. L

Volltext

Chronic cortisol suppresses pituitary and hypothalamic peptide message expression in pigtailed macaques von Szot, P, Wilkinson, C.W, White, S.S, Leverenz, J.B, Greenup, J.L, Colasurdo, E.A, Peskind, E.R, Raskind, M.A

Volltext

P4.022 Memantine monotherapy is effective andsafe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial von Peskind, E.R., Potkin, S.G., Pomara, N., Ott, B.R., McDonald, S., Xie, Y., Gergel, I.

Volltext

P4.012 Memantine treatment for mild to severeAlzheimer's disease: Clinical trials summary von Tariot, P.N., Doody, R.S., Peskind, E.R., Winblad, H., Stoeffler, A., Moebius, H.J., Grahams, S.M., McDonalds, S.

Volltext

180. Glucoocorticoid feedback inhibition of the HPA axis in PTSD von Kanter, E.D., Peskind, E.R., Dobie, D.J., Wilkinson, C.W., Raskind, M.A.

Volltext

CSF epinephrine in aging and Alzheimer's disease von Peskind, E.R., Elrod, R., Digiacomo, L., Veith, R.C., Raskind, M.A.

Volltext